Loss of transcription factor AP-2gamma/TFAP2C impairs branching morphogenesis of the murine mammary gland

Developmental Dynamics

Volumn 239, Issue 3, 2010, Pages 1027-1033

  Jäger, Richard ^a,b   Schäfer, Sabine ^a   Hau Liersch, Mathilde ^a   Schorle, Hubert ^a  

^a UNIVERSITY OF BONN   (Germany)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

AP 2; Branching morphogenesis; Mammary; TFAP2C; Transgenic mice

Indexed keywords

ESTROGEN RECEPTOR; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2 GAMMA; UNCLASSIFIED DRUG;

ARTICLE; BRANCHING MORPHOGENESIS; BREAST EPITHELIUM; CELL PROLIFERATION; HEREDITY; MAMMARY GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOTYPE; MAMMARY GLANDS, ANIMAL; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MORPHOGENESIS; OVARY; PHENOTYPE; RECEPTORS, ESTROGEN; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS;

MURINAE; MUS; MUS MUSCULUS;

EID: 77149180386     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.22239     Document Type: Article

References (22)

1. Auman HJ, Nottoli T, Lakiza O, Winger Q, Donaldson S, Williams T. 2002. Transcription factor AP-2gamma is essential in the extra-embryonic lineages for early postimplantation development. Development 129:2733-2747.
2. Eckert D, Buhl S, Weber S, Jager R, Schorle H. 2005. The AP-2 family of transcription factors. Genome Biol 6: 246.
3. Friedrichs N, Jager R, Paggen E, Rudlowski C, Merkelbach-Bruse S, Schorle H, Buettner R. 2005. Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer. Mod Pathol 18:431-438.
4. Friedrichs N, Steiner S, Buettner R, Knoepfle G. 2007. Immunohistochemical expression patterns of AP2alpha and AP2gamma in the developing fetal human breast. Histopathology 51:814-823.
5. Gee JM, Eloranta JJ, Ibbitt JC, Robertson JF, Ellis IO, Williams T, Nicholson RI, Hurst HC. 2009. Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to antihormone therapy and reduced patient survival. J Pathol 217:32-41.
6. Grimm SL, Bu W, Longley MA, Roop DR, Li Y, Rosen JM. 2006. Keratin 6 is not essential for mammary gland development. Breast Cancer Res 8:R29.
7. Guttormsen J, Koster MI, Stevens JR, Roop DR, Williams T, Winger QA. 2008. Disruption of epidermal specific gene expression and delayed skin development in AP-2 gamma mutant mice. Dev Biol 317:187-195.
8. Hayashi S, Lewis P, Pevny L, McMahon AP. 2002. Ef.cient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain. Mech Dev 119(Suppl 1):S97-S101.
9. Hennighausen L, Robinson GW. 2005. Information networks in the mammary gland. Nat Rev Mol Cell Biol 6:715-725.
10. Hinck L, Silberstein GB. 2005. Key stages in mammary gland development: the mammary end bud as a motile organ. Breast Cancer Res 7:245-251.
11. Kirfel J, Magin TM, Reichelt J. 2003. Keratins: a structural scaffold with emerging functions. Cell Mol Life Sci 60:56-71.
12. Mikaelian I, Hovick M, Silva KA, Burzenski LM, Shultz LD, Ackert-Bicknell CL, Cox GA, Sundberg JP. 2006. Expression of terminal differentiation proteins de.nes stages of mouse mammary gland development. Vet Pathol 43:36-49.
13. Ruan W, Monaco ME, Kleinberg DL. 2005. Progesterone stimulates mammary gland ductal morphogenesis by synergizing with and enhancing insulin-like growth factor-I action. Endocrinology 146:1170-1178.
14. Schorle H, Meier P, Buchert M, Jaenisch R, Mitchell PJ. 1996. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 381:235-238.
15. Sternlicht MD, Kouros-Mehr H, Lu P, Werb Z. 2006. Hormonal and local control of mammary branching morphogenesis. Differentiation 74:365-381.
16. Wang X, Pasolli HA, Williams T, Fuchs E. 2008. AP-2 factors act in concert with Notch to orchestrate terminal differentiation in skin epidermis. J Cell Biol 183: 37-48.
17. Weber S, Eckert D, Nettersheim D, Gillis AJ, Schafer S, Kuckenberg P, Ehlermann J, Werling U, Biermann K, Looijenga LH, Schorle H. 2009. Critical function of AP-2gamma/TCFAP2C in mouse embryonic germ cell maintenance. Biol Reprod 82:214-223.
18. Werling U, Schorle H. 2002a. Conditional inactivation of transcription factor AP-2gamma by using the Cre/loxP recombination system. Genesis 32:127-129.
19. Werling U, Schorle H. 2002b. Transcription factor gene AP-2 gamma essential for early murine development. Mol Cell Biol 22:3149-3156.
20. Woodfield GW, Horan AD, Chen Y, Weigel RJ. 2007. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling. Cancer Res 67:8439-8443.
21. Woodfield GW, Hitchler MJ, Chen Y, Domann FE, Weigel RJ. 2009. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure. Clin Cancer Res 15:3672-3679.
22. Zhang J, Hagopian-Donaldson S, Serbedzija G, Elsemore J, Plehn-Dujowich D, McMahon AP, Flavell RA, Williams T. 1996. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 381:238-241.